Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors

NCT07421518 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Type 2 Diabetes

Interventions

DRUG: SGLT-2 inhibitor (Sotagliflozin)
OTHER: Insulin withdrawal test (IWT)

Sponsor

AdventHealth Translational Research Institute